Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma.
Delord JP, Tabernero J, García-Carbonero R, Cervantes A, Gomez-Roca C, Bergé Y, Capdevila J, Paz-Ares L, Roda D, Delmar P, Oppenheim D, Brossard SS, Farzaneh F, Manenti L, Passioukov A, Ott MG, Soria JC. Delord JP, et al. Among authors: passioukov a. Eur J Cancer. 2014 Feb;50(3):496-505. doi: 10.1016/j.ejca.2013.10.015. Epub 2013 Nov 18. Eur J Cancer. 2014. PMID: 24262587 Clinical Trial.
An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinoma.
Temam S, Spicer J, Farzaneh F, Soria JC, Oppenheim D, McGurk M, Hollebecque A, Sarini J, Hussain K, Soehrman Brossard S, Manenti L, Evers S, Delmar P, Di Scala L, Mancao C, Feuerhake F, Andries L, Ott MG, Passioukov A, Delord JP. Temam S, et al. Among authors: passioukov a. Ann Oncol. 2017 Nov 1;28(11):2827-2835. doi: 10.1093/annonc/mdx489. Ann Oncol. 2017. PMID: 28950289 Free PMC article. Clinical Trial.
Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy.
Oppenheim DE, Spreafico R, Etuk A, Malone D, Amofah E, Peña-Murillo C, Murray T, McLaughlin L, Choi BS, Allan S, Belousov A, Passioukov A, Gerdes C, Umaña P, Farzaneh F, Ross P. Oppenheim DE, et al. Among authors: passioukov a. Br J Cancer. 2014 Mar 4;110(5):1221-7. doi: 10.1038/bjc.2014.35. Epub 2014 Feb 4. Br J Cancer. 2014. PMID: 24496456 Free PMC article.
Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984).
Biesma B, Manegold C, Smit HJ, Willems L, Legrand C, Passioukov A, van Meerbeeck JP, Giaccone G; EORTC Lung Cancer Group. Biesma B, et al. Among authors: passioukov a. Eur J Cancer. 2006 Jul;42(10):1399-406. doi: 10.1016/j.ejca.2006.01.049. Epub 2006 Jun 8. Eur J Cancer. 2006. PMID: 16759850 Clinical Trial.
TuBaFrost 4: access rules and incentives for a European tumour bank.
Lopez-Guerrero JA, Riegman PH, Oosterhuis JW, Lam KH, Oomen MH, Spatz A, Ratcliffe C, Knox K, Mager R, Kerr D, Pezzella F, van Damme B, van de Vijver M, van Boven H, Morente MM, Alonso S, Kerjaschki D, Pammer J, Carbone A, Gloghini A, Teodorovic I, Isabelle M, Passioukov A, Lejeune S, Therasse P, van Veen EB, Dinjens WN, Llombart-Bosch A. Lopez-Guerrero JA, et al. Among authors: passioukov a. Eur J Cancer. 2006 Nov;42(17):2924-9. doi: 10.1016/j.ejca.2006.04.030. Epub 2006 Oct 5. Eur J Cancer. 2006. PMID: 17027256 Review.
TuBaFrost 1: Uniting local frozen tumour banks into a European network: an overview.
Riegman PH, Dinjens WN, Oomen MH, Spatz A, Ratcliffe C, Knox K, Mager R, Kerr D, Pezzella F, van Damme B, van de Vijver M, van Boven H, Morente MM, Alonso S, Kerjaschki D, Pammer J, Lopez-Guerrero JA, Llombart Bosch A, Carbone A, Gloghini A, Teodorovic I, Isabelle M, Jaminé D, Passioukov A, Lejeune S, Therasse P, van Veen EB, Lam KH, Oosterhuis JW. Riegman PH, et al. Among authors: passioukov a. Eur J Cancer. 2006 Nov;42(16):2678-83. doi: 10.1016/j.ejca.2006.04.031. Epub 2006 Oct 5. Eur J Cancer. 2006. PMID: 17027254
TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe.
van Veen EB, Riegman PH, Dinjens WN, Lam KH, Oomen MH, Spatz A, Mager R, Ratcliffe C, Knox K, Kerr D, van Damme B, van de Vijver M, van Boven H, Morente MM, Alonso S, Kerjaschki D, Pammer J, Lopez-Guerrero JA, Llombart Bosch A, Carbone A, Gloghini A, Teodorovic I, Isabelle M, Passioukov A, Lejeune S, Therasse P, Oosterhuis JW. van Veen EB, et al. Among authors: passioukov a. Eur J Cancer. 2006 Nov;42(17):2914-23. doi: 10.1016/j.ejca.2006.04.028. Epub 2006 Oct 6. Eur J Cancer. 2006. PMID: 17029786 Review.
TuBaFrost 6: virtual microscopy in virtual tumour banking.
Teodorovic I, Isabelle M, Carbone A, Passioukov A, Lejeune S, Jaminé D, Therasse P, Gloghini A, Dinjens WN, Lam KH, Oomen MH, Spatz A, Ratcliffe C, Knox K, Mager R, Kerr D, Pezzella F, van Damme B, van de Vijver M, van Boven H, Morente MM, Alonso S, Kerjaschki D, Pammer J, Lopez-Guerrero JA, Llombart Bosch A, van Veen EB, Oosterhuis JW, Riegman PH. Teodorovic I, et al. Among authors: passioukov a. Eur J Cancer. 2006 Dec;42(18):3110-6. doi: 10.1016/j.ejca.2006.04.033. Epub 2006 Oct 5. Eur J Cancer. 2006. PMID: 17027253
TuBaFrost: European virtual tumor tissue banking.
Riegman PH, Oomen MH, Dinjens WN, Oosterhuis JW, Lam KH, Spatz A, Ratcliffe C, Knox K, Mager R, Kerr D, Pezzella F, Van Damme B, Van De Vijver M, Van Boven H, Morente MM, Alonso S, Kerjaschki D, Pammer J, López-Guerrero JA, Llombart-Bosch A, Carbone A, Gloghini A, Teodorovic I, Isabelle M, Passioukov A, Lejeune S, Therasse P, Van Veen EB. Riegman PH, et al. Among authors: passioukov a. Adv Exp Med Biol. 2006;587:65-74. doi: 10.1007/978-1-4020-5133-3_6. Adv Exp Med Biol. 2006. PMID: 17163156 Review.
OECI TuBaFrost tumor biobanking.
Riegman PH, Bosch AL; OECI TuBaFrost Consortium. Riegman PH, et al. Tumori. 2008 Mar-Apr;94(2):160-3. doi: 10.1177/030089160809400205. Tumori. 2008. PMID: 18564601
18 results